Viking Therapeutics, Inc.
SAN DIEGO, CA · Founded 2012 · CIK 0001607678 · Biotech · Public
Small-molecule and biologic therapeutics for obesity and metabolic disease
vikingtherapeutics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $3.7M
- 1 Form D · Jun 2017
- 112 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 10 granted · 30 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $3,656,038 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3293 | Oryn Therapeutics, Inc. | — | — |
| 3294 | Inflamma Therapeutics, LLC | — | — |
| 3295 | CELLCHORUS INC. | — | — |
| 3296 | Viking Therapeutics, Inc. | — | $3.7M |
| 3297 | PHELIX THERAPEUTICS LLC | — | — |
| 3298 | Ferment Labs, Inc. | — | $900K |
| 3299 | Rhamnolipid, Inc. | — | $1.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Matthew FoehrDirector
- Brian LianDirector · Executive Officer
- Lawson MacartneyDirector
- Michael MorneauExecutive Officer
- J. SingletonDirector
- Stephen WebsterDirector
Patents
- Compositions And Methods For The Treatment Of Liver Disordersgranted
- Compositions And Methods For The Treatment Of Metabolic And Liver Disordersapplication
- Pharmaceutical Formulations And Methods For The Treatment Of Metabolic And Liver Disordersapplication
- Compositions And Methods For The Treatment Of Metabolic And Liver Disordersapplication
- Compositions And Methods For The Treatment Of Metabolic And Liver Disordersapplication
- Compositions And Methods For The Treatment Of Metabolic And Liver Disordersgranted
- Compositions And Methods For The Treatment Of Metabolic And Liver Disordersgranted
- Compositions And Methods For The Treatment Of Metabolic And Liver Disordersgranted
- Pharmaceutical Formulations And Methods For The Treatment Of Metabolic And Liver Disordersapplication
- Oral Dosage Forms Of Trî² Agonist VK2809 For The Treatment Of Liver Disorders And Methods Of Preparing The Sameapplication
- Crystalline Forms And Methods Of Producing Crystalline Forms Of A Compoundgranted
- Polymorphic Forms And Methods Of Producing Polymorphic Forms Of A Compoundapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.